Abstract
Alzheimer's disease (AD) is a progressive degenerative disorder that affects more than 35 millions of people throughout the world and still has no therapy able to stop its course or even prevent its instauration. Abnormal neurogenesis and neuroinflammation are processes inherent to pathogenesis of AD, and therefore signs that promote these processes can act as initial deleterious triggers…